Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 833

    1.

    Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.

    Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J, Nguyen MD, Schmidt AM, Zochodne DW.

    Diabetes. 2008 Apr;57(4):1002-17. Epub 2007 Nov 26.PMID: 18039814 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model.

    Brussee V, Guo G, Dong Y, Cheng C, Martinez JA, Smith D, Glazner GW, Fernyhough P, Zochodne DW.

    Diabetes. 2008 Jun;57(6):1664-73. Epub 2008 Mar 10.PMID: 18332094 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.

    Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP.

    J Clin Invest. 2004 Dec;114(12):1741-51.PMID: 15599399 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

    Vareniuk I, Pavlov IA, Obrosova IG.

    Diabetologia. 2008 Nov;51(11):2126-33. Epub 2008 Sep 19.PMID: 18802679 [PubMed - indexed for MEDLINE]Related articles

    5.

    Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

    Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM, Schmidt AM.

    Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):905-10.PMID: 11397695 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    RAGE, diabetes, and the nervous system.

    Toth C, Martinez J, Zochodne DW.

    Curr Mol Med. 2007 Dec;7(8):766-76. Review.PMID: 18331235 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nitric oxide synthase activity and expression in experimental diabetic neuropathy.

    Zochodne DW, Verge VM, Cheng C, Höke A, Jolley C, Thomsen K, Rubin I, Lauritzen M.

    J Neuropathol Exp Neurol. 2000 Sep;59(9):798-807.PMID: 11005260 [PubMed - indexed for MEDLINE]Related articles

    8.

    Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons.

    Scott JN, Clark AW, Zochodne DW.

    Brain. 1999 Nov;122 ( Pt 11):2109-18.PMID: 10545396 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?

    Kennedy JM, Zochodne DW.

    Diabetes. 2005 Mar;54(3):830-7.PMID: 15734862 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.

    Xu L, Li B, Cheng M, Zhang W, Pan J, Zhang C, Gao H.

    Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):215-24. Epub 2008 Feb 2.PMID: 18273752 [PubMed - indexed for MEDLINE]Related articles

    11.

    Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.

    Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, Koga J, Iwai M, Horiuchi M, Gang Z, Yamagishi S, Sunagawa K.

    J Mol Cell Cardiol. 2007 Oct;43(4):455-64. Epub 2007 Jul 21.PMID: 17761193 [PubMed - indexed for MEDLINE]Related articles

    12.

    Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.

    Vareniuk I, Pacher P, Pavlov IA, Drel VR, Obrosova IG.

    Int J Mol Med. 2009 May;23(5):571-80.PMID: 19360314 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Role of advanced glycation end products in diabetic neuropathy.

    Sugimoto K, Yasujima M, Yagihashi S.

    Curr Pharm Des. 2008;14(10):953-61. Review.PMID: 18473845 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice.

    Uehara K, Yamagishi S, Otsuki S, Chin S, Yagihashi S.

    Diabetes. 2004 Dec;53(12):3239-47.PMID: 15561956 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Does diabetes mellitus target motor neurons?

    Ramji N, Toth C, Kennedy J, Zochodne DW.

    Neurobiol Dis. 2007 May;26(2):301-11. Epub 2006 Dec 29.PMID: 17337195 [PubMed - indexed for MEDLINE]Related articles

    16.

    Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.

    Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.

    Diabetes. 2006 Aug;55(8):2245-55.PMID: 16873687 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.

    Samii A, Unger J, Lange W.

    Neurosci Lett. 1999 Mar 12;262(3):159-62.PMID: 10218880 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.

    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.

    Invest Ophthalmol Vis Sci. 2007 Feb;48(2):858-65.PMID: 17251488 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

    Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL.

    Diabetes. 2009 Oct;58(10):2376-85. Epub 2009 Jul 10.PMID: 19592619 [PubMed - indexed for MEDLINE]Related articles

    20.

    Role of advanced glycation end products and their receptors in development of diabetic neuropathy.

    Wada R, Yagihashi S.

    Ann N Y Acad Sci. 2005 Jun;1043:598-604. Review.PMID: 16037282 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data